| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/12/2007 | US7230103 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines |
| 06/12/2007 | US7230102 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments |
| 06/12/2007 | US7230099 Heterocyclic inhibitors of MEK and methods of use thereof |
| 06/12/2007 | US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 06/12/2007 | US7230088 Compounds for dual photodiagnosis and therapy |
| 06/12/2007 | US7230033 Pest control compositions and methods for their use |
| 06/12/2007 | US7230032 Calcium blockers to treat proliferative vitreoretinopathy |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230030 Ether, alcohol, ester, carbamate or carbonate,sulfamate or silanol substituted-3,3-diphenylpropylamine derivatives; prodrugs of antimuscarinic agents with superior pharmacokinetic properties |
| 06/12/2007 | US7230029 Fatty acid analogues for the treatment of proliferative skin disorders |
| 06/12/2007 | US7230028 Dimeric compounds and their use as anti-viral agents |
| 06/12/2007 | US7230027 citrus-based furocoumarins; for dietary supplements or medicinal foods; bioavailability |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230025 Pyrazole derivatives |
| 06/12/2007 | US7230024 such as 2-(2-chloro-phenyl)-5-isopropyl-3-(3,4,5-trifluoro-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one; for treatment of eating disorders and psychological disorders |
| 06/12/2007 | US7230023 Triazole compound containing a phosphonate group |
| 06/12/2007 | US7230022 Substituted fused bicyclic amines as modulators of chemokine receptor activity |
| 06/12/2007 | US7230021 Therapy for immunology sensitive disease; marine animal extract |
| 06/12/2007 | US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer |
| 06/12/2007 | US7230019 As neuroprotective agents in the therapy of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230018 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 06/12/2007 | US7230017 For therapy of neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230016 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| 06/12/2007 | US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 06/12/2007 | US7230014 For therapy of peptic ulcers with solution of an antiulcerative agent in isotonic solutions for intravenous administration, such as dextrose or sodium chloride, with high pH, and glycine-sodium hydroxide buffer; discoloration inhibition |
| 06/12/2007 | US7230013 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth |
| 06/12/2007 | US7230012 Pharmaceutical compositions and dosage forms of thalidomide |
| 06/12/2007 | US7230011 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht6 receptor |
| 06/12/2007 | US7230010 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 06/12/2007 | US7230009 Pyridoxal analogues and methods of treatment |
| 06/12/2007 | US7230008 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 06/12/2007 | US7230007 Antiarhythmia agents ; cardiovascular disorders; central nervous system disorders |
| 06/12/2007 | US7230006 For therapy of allergic syndromes |
| 06/12/2007 | US7230005 Compounds and methods for lowering the abuse potential and extending the duration of action of a drug |
| 06/12/2007 | US7230004 Cyclopamine analogues and methods of use thereof |
| 06/12/2007 | US7230003 Aromatic prodrugs of propofol, compositions and uses thereof |
| 06/12/2007 | US7230002 Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7230000 Administerig quinazolinone amide derivative for therapy of solid tumor |
| 06/12/2007 | US7229999 Pyridine-3-carboxamide derivatives as CB1 inverse agonists |
| 06/12/2007 | US7229998 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 06/12/2007 | US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists |
| 06/12/2007 | US7229996 For therapy and prophylaxis of infectious diseases in mammals, both humans and non-humans, having antibacterial activity against drug-resistant bacteria |
| 06/12/2007 | US7229995 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 06/12/2007 | US7229994 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/12/2007 | US7229993 Aryl substituted pyrimidines and the use thereof |
| 06/12/2007 | US7229992 Process for the preparation of a piperazine derivative |
| 06/12/2007 | US7229991 Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides |
| 06/12/2007 | US7229990 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies. |
| 06/12/2007 | US7229989 When used in photochromic eyeglass lenses, produce essentially blue color tones which have a high darkening capacity |
| 06/12/2007 | US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229986 Melanin-concentrating hormone antagonist |
| 06/12/2007 | US7229985 2-(1-isopropoxy-carbonyloxy-2-methylpropyl)-7, 8-dimethoxy-4(5H), 10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine having a solubility of 15-20 mu g/mL in a 1 wt % methylcellulose solution at 37 degrees and a polymer, especially methylcellulose and/or hydroxypropylmethylcellulose. |
| 06/12/2007 | US7229984 Dibenzoxazepinone derivatives and uses thereof |
| 06/12/2007 | US7229983 antibacterial; beta -lactam antibiotics |
| 06/12/2007 | US7229982 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; for treatment of atheroslerosis |
| 06/12/2007 | US7229980 Including salts and mixtures with deoxycholic acid, glycocholic acid, taurocholic acid; can be formulated into an oral preparation for swallowing without water as an orally disintegrating tablet for paroxetine. |
| 06/12/2007 | US7229979 Delivery of drug coated stent; administered systemically; antiinflammatory and antiproliferative agents |
| 06/12/2007 | US7229978 Chloromethylating an alcohol or phenol, especially camptothecin, propofol, etoposide, vitamin E, or cyclosporin A, and reacting the product with phosphoric acid in the presence of a base in a suitable polar aprotic solvent |
| 06/12/2007 | US7229975 DNA immunization against chlamydia infection |
| 06/12/2007 | US7229974 Used to diagnose or treat cancer, restenosis, a disease caused by a virus, a disease affected by integrins or cell-cell adhesion receptor or a disease triggered by diffusible factors |
| 06/12/2007 | US7229973 pH-sensitive polymeric micelles for drug delivery |
| 06/12/2007 | US7229972 3,6-Bicyclolides |
| 06/12/2007 | US7229970 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/12/2007 | US7229969 Dipeptidyl peptidaseIV and alanyl-aminopeptidase inhibitors |
| 06/12/2007 | US7229963 Using enzyme inhibitors of histone deacetylase to enhance progenitor cell differentiation; regenerative medicine and treatment of nervous system disorders |
| 06/12/2007 | US7229961 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 06/12/2007 | US7229773 Screening method for apoptosis-suppressing or-promoting substance |
| 06/12/2007 | US7229770 YKL-40 as a marker and prognostic indicator for cancers |
| 06/12/2007 | US7229653 Increasing the HDL level and the HDL/LDL ratio in human serium by balancing saturated and polyunsaturated dietary fatty acids |
| 06/12/2007 | US7229650 by applying a topical composition containing an effective amount of an extract of feverfew to the skin; extract is substantially free of alpha -unsaturated gamma -lactone particularly parthenolide |
| 06/12/2007 | US7229649 Method and composition for improving sexual fitness |
| 06/12/2007 | US7229648 Homeopathic formulations useful for treating pain and/or inflammation |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | US7229645 Spray freeze-dried compositions |
| 06/12/2007 | US7229644 Pharmaceutical formulations of modafinil |
| 06/12/2007 | US7229643 Solid oral formulation coated with hydroxypropyl methylcellulose; the polymer coating is free of polyethylene glycol |
| 06/12/2007 | US7229640 Paroxetine controlled release compositions |
| 06/12/2007 | US7229639 Antiinflammatory agents, analgesics, antiarthritic agents; liquid filled capsulaes |
| 06/12/2007 | US7229637 Food additives |
| 06/12/2007 | US7229635 Pharmacotherapeutic process and composition for central nervous system disorders |
| 06/12/2007 | US7229633 Biological bioadhesive compositions and methods of preparation and use |
| 06/12/2007 | US7229630 Reverse of anesthetic |
| 06/12/2007 | US7229629 Oxidation resistance |
| 06/12/2007 | US7229628 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/12/2007 | US7229613 Method for lowering serum glucose |
| 06/12/2007 | US7229607 Treatment of respiratory disease |
| 06/12/2007 | US7229557 Providing a racemic mixture comprising d-threo-methylphenidate and l-threo-methylphenidate; treating racemic mixture with dibenzoyl-L-tartrate, supplying l-fenchyloxyacetic acid; treating second mixture with l-fenchyloxyacetic acid; collecting d-threo-methylphenidate |
| 06/12/2007 | US7229447 Photodynamic therapy utilizing a solution of photosensitizing compound and surfactant |
| 06/12/2007 | CA2417264C Crystalline therapeutic agent |
| 06/12/2007 | CA2393758C Unsaturated 14,15-cyclopropano-androstanes |
| 06/12/2007 | CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors |
| 06/12/2007 | CA2382581C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/12/2007 | CA2366624C 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents |
| 06/12/2007 | CA2354023C Phenylglycine derivatives |
| 06/12/2007 | CA2326510C Dextran formulations and method for treatment of inflammatory joint disorders |
| 06/12/2007 | CA2316985C Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer |
| 06/12/2007 | CA2287257C 1,2,4-benzotriazine oxides formulations |
| 06/12/2007 | CA2285445C 4-tetrahydropyridylpyrimidine derivative |